Ovid Therapeutics Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · New York, NY
OVID chart
What traders are saying about $OVID
Latest postsOvid Therapeutics Inc. news
- Ovid Therapeutics Inc. Estimates – NASDAQ:OVID
TradingView ·
- Actinium Pharmaceuticals Strengthens Leadership Team with Appointment of Matt David, M.D. as Chief Financial Officer
Yahoo Finance ·
- Ovid Therapeutics (OVID) Stock Gets Fair Value Boost As Analysts Focus On OV329
Yahoo Finance ·
- Ovid Therapeutics (OVID) Cashes In One Bet To Fund Its Next Two
Yahoo Finance ·
- Ovid Therapeutics to Participate in Upcoming Investor Conferences
Yahoo Finance ·
- What Makes Ovid Therapeutics (OVID) a Strong Momentum Stock: Buy Now?
Yahoo Finance ·
- Ovid Therapeutics (OVID) Reports Q2 Loss, Beats Revenue Estimates
Yahoo Finance ·
- Ovid Therapeutics Reports Business Updates and Second Quarter 2026 Financial Results
Yahoo Finance ·
- Outlook Therapeutics, Inc. (OTLK) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
Yahoo Finance ·
- Lexicon Pharmaceuticals (LXRX) Reports Q2 Loss, Lags Revenue Estimates
Yahoo Finance ·
- Earnings Preview: Ovid Therapeutics (OVID) Q2 Earnings Expected to Decline
Yahoo Finance ·
- Ovid Therapeutics (OVID) Appoints Kevin Norrett as Chief Business Officer
Yahoo Finance ·
Ovid Therapeutics Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $7.3M | $566,000 | $392,000 | $1.5M |
| Net income | -$17.4M | -$26.4M | -$52.3M | -$54.2M |
| Diluted EPS | – | – | $-0.74 | $-0.77 |
| Total assets (year end) | $150.9M | $92.2M | $144.0M | $155.3M |
| Cash and equivalents (year end) | $13.2M | $26.3M | $27.0M | $44.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Ovid Therapeutics Inc.
- Ticker
- OVID (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- New York, NY
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1636651
Frequently asked questions
What exchange is Ovid Therapeutics Inc. listed on?
Ovid Therapeutics Inc. trades on the Nasdaq under the ticker symbol OVID.
What industry is Ovid Therapeutics Inc. in?
Ovid Therapeutics Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Ovid Therapeutics Inc. headquartered?
Ovid Therapeutics Inc.'s business address on file with the SEC is in New York, NY.
When does Ovid Therapeutics Inc.'s fiscal year end?
Ovid Therapeutics Inc.'s fiscal year ends on December 31.
How much revenue did Ovid Therapeutics Inc. report?
Ovid Therapeutics Inc. reported $7.3M in revenue for calendar year 2025, according to its SEC filings.